PL3368006T3 - Zastosowanie terapeutyczne sterylnego wodnego roztworu oftalmicznego - Google Patents

Zastosowanie terapeutyczne sterylnego wodnego roztworu oftalmicznego

Info

Publication number
PL3368006T3
PL3368006T3 PL16787868T PL16787868T PL3368006T3 PL 3368006 T3 PL3368006 T3 PL 3368006T3 PL 16787868 T PL16787868 T PL 16787868T PL 16787868 T PL16787868 T PL 16787868T PL 3368006 T3 PL3368006 T3 PL 3368006T3
Authority
PL
Poland
Prior art keywords
therapeutic use
sterile aqueous
ophthalmic solution
aqueous ophthalmic
solution
Prior art date
Application number
PL16787868T
Other languages
English (en)
Inventor
Martin Prinz
Sonja HÖLLER
Original Assignee
Croma-Pharma Gesellschaft M.B.H.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Croma-Pharma Gesellschaft M.B.H. filed Critical Croma-Pharma Gesellschaft M.B.H.
Publication of PL3368006T3 publication Critical patent/PL3368006T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL16787868T 2015-10-30 2016-10-27 Zastosowanie terapeutyczne sterylnego wodnego roztworu oftalmicznego PL3368006T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15192361 2015-10-30
PCT/EP2016/075938 WO2017072235A1 (en) 2015-10-30 2016-10-27 Therapeutic use of a sterile aqueous ophthalmic solution
EP16787868.5A EP3368006B1 (en) 2015-10-30 2016-10-27 Therapeutic use of a sterile aqueous ophthalmic solution

Publications (1)

Publication Number Publication Date
PL3368006T3 true PL3368006T3 (pl) 2020-06-01

Family

ID=54476730

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16787868T PL3368006T3 (pl) 2015-10-30 2016-10-27 Zastosowanie terapeutyczne sterylnego wodnego roztworu oftalmicznego

Country Status (14)

Country Link
US (1) US10813943B2 (pl)
EP (1) EP3368006B1 (pl)
JP (1) JP2018532753A (pl)
KR (1) KR20180066240A (pl)
CN (1) CN108348457A (pl)
AR (1) AR106493A1 (pl)
BR (1) BR112018008650A2 (pl)
CA (1) CA3003535A1 (pl)
ES (1) ES2773537T3 (pl)
IL (1) IL259049A (pl)
MX (1) MX2018005453A (pl)
PL (1) PL3368006T3 (pl)
RU (1) RU2018119674A (pl)
WO (1) WO2017072235A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018202783A1 (en) 2017-05-03 2018-11-08 Croma-Pharma Gmbh Sterile aqueous ophthalmic solution containing n-(n-acetylcysteinyl)-chitosan for treating non-infectious corneal disorders

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE431258B (sv) 1982-07-02 1984-01-23 Tiru Maj Britt Ingegerd Komposition med reglerad forendring av opalescens eller uppklarning vid valda temperaturer och sett for dess framstellning samt anvendning av kompositionen
IT1258781B (it) 1992-01-16 1996-02-29 Zambon Spa Composizione farmaceutica oftalmica contenente n-acetilcisteina e polivinilalcol
FR2692582B1 (fr) 1992-06-18 1998-09-18 Flamel Tech Sa Nouveaux derives reticulables de collagene, leur procede d'obtention et leur application a la preparation de biomateriaux.
AT406054B (de) 1998-11-04 2000-02-25 Andreas Bernkop-Schnuerch Verfahren zur verbesserung der mucoadhäsion von polymeren sowie deren herstellung und verwendung
CA2597525A1 (en) * 2005-02-17 2006-08-24 Senju Pharmaceutical Co., Ltd. Solid ophthalmic drug for external use
EP2107913B1 (en) 2006-12-22 2012-02-15 Croma-Pharma Gesellschaft m.b.H. Use of thiolated polysaccharides for tissue augmentation
WO2008094659A2 (en) 2007-01-31 2008-08-07 Allergan, Inc. Novel biomaterials for ocular drug delivery and a method for making and using same
US9452592B2 (en) 2007-08-28 2016-09-27 Cryovac, Inc. Multilayer film having an active oxygen barrier layer with radiation enhanced active barrier properties
EP2296637B1 (en) 2008-04-24 2014-04-02 Medtronic, Inc Chitosan-containing protective composition
JP5711113B2 (ja) 2008-04-24 2015-04-30 メドトロニック,インコーポレイテッド チオール化キトサンゲル
CA2721937C (en) 2008-04-24 2016-07-12 Medtronic, Inc. Protective gel based on chitosan and oxidized polysaccharide
ES2773017T3 (es) * 2010-04-06 2020-07-09 Synedgen Inc Derivados de quitosano para el tratamiento de mucositis o ulceración
EP3139903B1 (en) 2014-05-07 2019-07-03 Croma-Pharma Gesellschaft m.b.H. Aqueous ophthalmic solution and method for treating dry eye syndrome

Also Published As

Publication number Publication date
JP2018532753A (ja) 2018-11-08
EP3368006A1 (en) 2018-09-05
WO2017072235A1 (en) 2017-05-04
US10813943B2 (en) 2020-10-27
MX2018005453A (es) 2018-08-01
KR20180066240A (ko) 2018-06-18
EP3368006B1 (en) 2019-12-04
RU2018119674A3 (pl) 2019-12-02
US20180296589A1 (en) 2018-10-18
IL259049A (en) 2018-07-31
ES2773537T3 (es) 2020-07-13
AR106493A1 (es) 2018-01-17
CN108348457A (zh) 2018-07-31
CA3003535A1 (en) 2017-05-04
RU2018119674A (ru) 2019-12-02
BR112018008650A2 (pt) 2018-10-30

Similar Documents

Publication Publication Date Title
IL252648B (en) Systems for providing non-invasive nerve rehabilitation to the patient
LT3122878T (lt) Terapija mrnr, skirta akių ligų gydymui
PT3212233T (pt) Terapia combinada para o tratamento de doenças
SG11201608616VA (en) Patient interfaces
PT3273955T (pt) Tratamento de doenças respiratórias
IL250990A0 (en) Materials for human care
EP3212170A4 (en) Implantable medical devices for extended release of therapeutic agents
SG11201705138QA (en) Aqueous ophthalmic solution
PL3097085T3 (pl) Pochodne benzoksazynonu do leczenia chorób skóry
SG11201608257RA (en) A device for a medical treatment of a sclera
SMT202100082T1 (it) Composti eteroarilici per il trattamento di malattie oftalmiche
GB2538923B (en) A therapeutic agent for use in the treatment of infections
PL3151814T3 (pl) Leczenie zmiany skórnej
GB2541840B (en) Ophthalmic composition for the treatment of ocular infection
PT3047824T (pt) Dispositivo para tratamento a laser de um olho humano
IL258785A (en) Sterile aqueous solution for ophthalmic use
IL259381B (en) Mirabegron for the treatment of retinal diseases
PL3689341T3 (pl) Gabapentyna okulistyczna do leczenia deepitelializacji rogówki
IL259049A (en) Therapeutic use of a sterile aqueous ophthalmic solution
IL275150A (en) System for hypothermia treatment of a patient
HK1260500A1 (en) Therapeutic use of a sterile aqueous ophthalmic solution
EP3212202A4 (en) Use of therapeutic agents
GB201501800D0 (en) Treatment of medical conditions
AU2014904330A0 (en) Use of therapeutic agents
SG11201700331RA (en) Prophylactic or therapeutic agent for a posterior ocular disease